Patricia A. Ganz

Public Health, Environmental and Occupational Health · 2000–2021

A researcher in the Science corpus: 15 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Public Health, Environmental and Occupational Health — 39 citations into it
• General Health Professions — 27 citations into it
• Psychiatry and Mental health — 9 citations into it

Whom Patricia A. Ganz trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. L. Clark

Who trusts Patricia A. Ganz overall

1. M. Hewitt
2. J. Bower

Papers from Patricia A. Ganz's perspective

Ordered by how strongly the researchers Patricia A. Ganz trusts endorse each paper. Same corpus, a different order for every researcher.

1. Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. (Journal of the National Cancer Institute)
2. SF-36 health survey: Manual and interpretation guide
3. Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. (Journal of the National Cancer Institute)
4. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. (Journal of Clinical Oncology)
5. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. (Journal of Clinical Oncology)
6. CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. (Journal of the National Cancer Institute)
7. Side effects of adjuvant treatment of breast cancer. (New England Journal of Medicine)
8. The pattern of human concerns
9. Development and validation of brief measures of positive and negative affect: the PANAS scales.
10. Effect of screening and adjuvant therapy on mortality from breast cancer. (New England Journal of Medicine)

Their papers

• Rapid-learning system for cancer care. (2010) — 344 citations
• American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options. (2015) — 818 citations
• Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer (2021) — 1,293 citations
• American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline (2016) — 1,223 citations
• Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis (2014) — 1,221 citations
• Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. (2012) — 814 citations
• Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers with Cancer Risk and Mortality (2010) — 1,383 citations
• Update of the National Surgical Adjvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer (2010) — 629 citations
• Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT) (2008) — 2,160 citations
• Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. (2006) — 1,648 citations
• Fatigue in long‐term breast carcinoma survivors (2006) — 704 citations
• Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. (2002) — 1,097 citations
• Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. (2001) — 634 citations
• Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. (2000) — 1,152 citations
• Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. (2000) — 624 citations